Anti-CD19 chimeric antigen receptor T-cell therapy for relapsed or refractory Philadelphia chromosome-positive B cell acute lymphoblastic leukemia: a multicenter retrospective study.
Saved in:
| Title: | Anti-CD19 chimeric antigen receptor T-cell therapy for relapsed or refractory Philadelphia chromosome-positive B cell acute lymphoblastic leukemia: a multicenter retrospective study. |
|---|---|
| Authors: | Yu J; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Road, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Song F; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Road, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Zhang M; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Road, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Zhao M; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China., Sang W; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China., Jiang S; Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China., Wang L; Department of Hematology and Oncology, International Cancer Center, Shenzhen Key Laboratory, Hematology Institution of Shenzhen University, Shenzhen University General Hospital, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, China., Wang X; Division of Life Sciences and Medicine, Department of Hematology, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), University of Science and Technology of China, Hefei, Anhui, China., Tu S; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China., Li Y; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China., Huang H; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Road, Hangzhou, China. huanghe@zju.edu.cn.; Institute of Hematology, Zhejiang University, Hangzhou, China. huanghe@zju.edu.cn.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China. huanghe@zju.edu.cn., Hu Y; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Road, Hangzhou, China. 1313016@zju.edu.cn.; Institute of Hematology, Zhejiang University, Hangzhou, China. 1313016@zju.edu.cn.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China. 1313016@zju.edu.cn., Wei G; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Road, Hangzhou, China. weiguoqing2018@zju.edu.cn.; Institute of Hematology, Zhejiang University, Hangzhou, China. weiguoqing2018@zju.edu.cn.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China. weiguoqing2018@zju.edu.cn. |
| Source: | BMC medicine [BMC Med] 2026 Mar 03; Vol. 24 (1). Date of Electronic Publication: 2026 Mar 03. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015 (Electronic) Linking ISSN: 17417015 NLM ISO Abbreviation: BMC Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41776492 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Anti-CD19 chimeric antigen receptor T-cell therapy for relapsed or refractory Philadelphia chromosome-positive B cell acute lymphoblastic leukemia: a multicenter retrospective study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yu+J%22">Yu J</searchLink>; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Road, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Song+F%22">Song F</searchLink>; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Road, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhang+M%22">Zhang M</searchLink>; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Road, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhao+M%22">Zhao M</searchLink>; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Sang+W%22">Sang W</searchLink>; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Jiang+S%22">Jiang S</searchLink>; Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Department of Hematology and Oncology, International Cancer Center, Shenzhen Key Laboratory, Hematology Institution of Shenzhen University, Shenzhen University General Hospital, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, China.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Division of Life Sciences and Medicine, Department of Hematology, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), University of Science and Technology of China, Hefei, Anhui, China.<br /><searchLink fieldCode="AU" term="%22Tu+S%22">Tu S</searchLink>; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Huang+H%22">Huang H</searchLink>; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Road, Hangzhou, China. huanghe@zju.edu.cn.; Institute of Hematology, Zhejiang University, Hangzhou, China. huanghe@zju.edu.cn.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China. huanghe@zju.edu.cn.<br /><searchLink fieldCode="AU" term="%22Hu+Y%22">Hu Y</searchLink>; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Road, Hangzhou, China. 1313016@zju.edu.cn.; Institute of Hematology, Zhejiang University, Hangzhou, China. 1313016@zju.edu.cn.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China. 1313016@zju.edu.cn.<br /><searchLink fieldCode="AU" term="%22Wei+G%22">Wei G</searchLink>; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Road, Hangzhou, China. weiguoqing2018@zju.edu.cn.; Institute of Hematology, Zhejiang University, Hangzhou, China. weiguoqing2018@zju.edu.cn.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China. weiguoqing2018@zju.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101190723%22">BMC medicine</searchLink> [BMC Med] 2026 Mar 03; Vol. 24 (1). <i>Date of Electronic Publication: </i>2026 Mar 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101190723 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1741-7015 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217417015%22">17417015 </searchLink><i>NLM ISO Abbreviation: </i>BMC Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41776492 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12916-026-04755-6 Languages: – Code: eng Text: English Titles: – TitleFull: Anti-CD19 chimeric antigen receptor T-cell therapy for relapsed or refractory Philadelphia chromosome-positive B cell acute lymphoblastic leukemia: a multicenter retrospective study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yu J – PersonEntity: Name: NameFull: Song F – PersonEntity: Name: NameFull: Zhang M – PersonEntity: Name: NameFull: Zhao M – PersonEntity: Name: NameFull: Sang W – PersonEntity: Name: NameFull: Jiang S – PersonEntity: Name: NameFull: Wang L – PersonEntity: Name: NameFull: Wang X – PersonEntity: Name: NameFull: Tu S – PersonEntity: Name: NameFull: Li Y – PersonEntity: Name: NameFull: Huang H – PersonEntity: Name: NameFull: Hu Y – PersonEntity: Name: NameFull: Wei G IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 03 Text: 2026 Mar 03 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1741-7015 Numbering: – Type: volume Value: 24 – Type: issue Value: 1 Titles: – TitleFull: BMC medicine Type: main |
| ResultId | 1 |
